Application of proton NMR spectroscopy in the study of lipid metabolites in a rat hepatocarcinogenesis model.
Liver cancer is one of the most common cancers worldwide. Altered lipid metabolism in the liver is a key feature of developing liver nodules and tumors. Methods of analysis vary from the most sophisticated chromatography to the in vivo nuclear magnetic resonance (NMR) spectroscopy. In this study, we present a systematic method for the identification and quantitation of signature signals from lipid metabolites using 1D NMR proton spectroscopy. We assessed lipid metabolites in an epigenetic rat hepatocarcinogenesis model induced by treatment with a choline-deficient diet (CDAA, choline-deficient l-amino acid defined) over a period of 1 year, from the formation of steatosis, to the development of nodules and adenomas. A comparable choline-sufficient (CSAA) diet was used for the controls. The resonances of the methylene protons of the glycerol backbone in phospholipids were used to quantify the total concentration of such compounds. CDAA rat livers were found to have significantly higher levels of phospholipids, when compared to CSAA, throughout the entire carcinogenesis period. The tri-methyl protons of choline compounds serves to quantify total choline, and the vinyl and bis-allyl proton resonances can be used to not only quantify fatty acid concentrations but also to probe the number of double bonds in a fatty acid moiety. Early stages of carcinogenesis indicate a lower degree of double bonds in fatty acyl containing compounds in CDAA rat livers, when compared to CSAA. The results of this study are in agreement with those previously published in the literature on other rat hepatocarcinogenesis models.
Tesiram
Y A
YA
Oklahoma Medical Research Foundation, Free Radical Biology and Aging Research Program, 825 NE 13th St, Oklahoma City, OK 73104, USA.
Saunders
D
D
Towner
R A
RA
D000818:Animals; D002794:Choline / Q000008:administration & dosage; D002796:Choline Deficiency / Q000150:complications* / Q000503:physiopathology; D003903:Deuterium; D004032:Diet; D004195:Disease Models, Animal; D005234:Fatty Liver / Q000209:etiology; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008103:Liver Cirrhosis / Q000209:etiology; D008114:Liver Neoplasms, Experimental / Q000209:etiology* / Q000473:pathology; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D051381:Rats; D011916:Rats, Inbred F344
D003903:Deuterium; D002794:Choline